Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing

Background There are indications of staggered market entry of medicines in the national markets, with medicines being marketed first in countries with high prices. This study aimed to analyse the availability and evolution of medicine prices in the European Union (EU).